Dr. James Francis Pingpank, MD

Dr. Pingpank practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Pingpank's NPI, 1154579720, was assigned on September 8, 2008. Dr. Pingpank graduated from George Washington University School of Medicine in 1992. Dr. Pingpank holds Pennsylvania license MD055945L.

Dr. Pingpank's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Pingpank's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Pingpank is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Pingpank to 4 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pingpank practices, 7 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Pingpank's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Pingpank is licensed in Pennsylvania.

CMS data shows 353 Medicare services from Dr. Pingpank across 9 procedure codes in 2024, for 150 Medicare patients. Medicare paid $34,250 for them.

CMS counts 150 Medicare patients who saw Dr. Pingpank in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pingpank's median patient age at 69, with 49% women.

In 2024, Dr. Pingpank wrote 70 Medicare Part D claims for 26 patients. 93% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $69 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Pingpank for performance year 2024, reported as part of a group. Dr. Pingpank accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pingpank as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 73 papers to Dr. Pingpank, published from 2010 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Peritoneal Neoplasms, Cytoreduction Surgical Procedures and Hyperthermia, Induced. Dr. Pingpank has published most often in Ann Surg Oncol. Dr. Pingpank's most frequent co-authors are David Lawrence Bartlett, MD, Matthew Peter Holtzman, MD and Amer H. Zureikat, MD.

CMS Open Payments shows 11 general payments to Dr. Pingpank from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Intuitive Surgical, Inc. paid the most, $210.

Dr. Pingpank graduated from George Washington University School of Medicine in 1992.